Objective Assessment of the Effects of Shift Work on Drowsiness and Driving Impairment in Hospital Staff
|ClinicalTrials.gov Identifier: NCT01672489|
Recruitment Status : Unknown
Verified August 2015 by Charles Andrew Czeisler, MD, PhD, Brigham and Women's Hospital.
Recruitment status was: Active, not recruiting
First Posted : August 27, 2012
Last Update Posted : August 10, 2015
|Condition or disease|
|Impaired Driving Sleep Driving|
Specific Aim 1. To test the hypothesis that on road (track) driving performance will deteriorate (variation in lateral lane position and the rate of out of lane driving events) and the frequency of episodes of severe sleepiness will increase ("microsleeps" on EEG and Johns' Drowsiness Score >4) in shift workers following an extended work shift or night shift compared to a rested state, following day shifts.
Specific Aim 2. To test the hypothesis that ocular measures of alertness (percent of time with eyes closed, eye tracking and Johns' Drowsiness Score) are related to abnormal driving performance (driving out of the lane) and "microsleeps" during on road (track) driving.
Specific Aim 2a. To test the hypothesis that autonomic measures, ECG, respiration (measured with the Bioharness), skin conductance level and peripheral blood flow (measured with the Q sensor), are related to abnormal driving performance (driving out of the lane) and "microsleeps" during on road (track) driving
Specific Aim 3. To test the hypothesis that self-reported sleepiness is related to on road (track) driving performance and episodes of severe sleepiness following extended working shifts or night shifts.
|Study Type :||Observational|
|Actual Enrollment :||19 participants|
|Official Title:||Objective Assessment of the Effects of Shift Work on Drowsiness and Driving Impairment in Hospital Staff|
|Study Start Date :||July 2011|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
- Brain activity including "microsleeps" using electroencephalography (EEG). [ Time Frame: Up to 3 hours per session for each participant. ]Continuous EEG recordings are made during each track driving session using a portable Vitaport 4 system (Temec ®).
- Participants' fatigue and drowsiness level while driving using Optalert. [ Time Frame: Up to 3 hours per session for each participant. ]Optalert is a portable device, worn like sunglasses, designed to detect drowsiness, particularly when driving.
- Driving performance measured by an instrumented vehicle. [ Time Frame: Up to 3 hours per session for each participant. ]A dual control instrumented vehicle, owned by Liberty Mutual, has been used for each driving session with each subject. This vehicle is fitted with a lane tracking system, as well as the capability to instruct and record responses from the driver. Lane position is monitored and recorded continuously with lateral and rear facing cameras. Data is logged to on-board computers.
- Alertness level and level of fatigue measured by a composite of variables from a Zephyr Bioharness device worn by each participant. [ Time Frame: Up to 3 hours per session for each participant. ]The Zephyr Bioharness uses smart fabric sensors (non-adhesive) to measure electrocardiography (ecg), respiratory wave form, chest skin temperature, posture and activity (3-axis accelerometer).
- Alertness level and level of fatigue from a composite of variables measured by an Affectiva Q-Sensor worn by each participant. [ Time Frame: Up to 3 hours per session for each participant. ]Additional autonomic nervous systems measures are obtained from a wrist-worn sensor (Affectiva Q-Sensor).
- Participants' fatigue and drowsiness level measured by an eye tracker device. [ Time Frame: Up to 3 hours per session for each participant. ]An eye tracking device, owned by Liberty Mutual, is used to measure eye activity.
- Participant's awareness of their fatigue level using a composite of survey data taken by each participant. [ Time Frame: Surveys are taken by the participant every 15 minutes during regular stops during each session. ]Questionnaires include: Karolinska Sleepiness Scale, Likelihood of Falling Asleep Questionnaire, and the Sleepiness Symptoms Questionnaire.
- Sleep and wake times using an Actiwatch device. [ Time Frame: Up to 7 weeks per subject worn continuously during enrollment in the study. ]The Actiwatch-L recorder is a small wrist worn device (17 grams) that measures activity and ambient light exposure.
- Sleep and wake times using a 'sleep and work' diary completed by each subject. [ Time Frame: Up to 7 weeks per participant completed daily. ]Subjects maintain a sleep/work diary to provide a self-assessment of their sleep quantity and quality, work periods, as well as caffeine, medication, and alcohol intake.
- Participants' view of their health and well-being using a composite of surveys administered during subject enrollment. [ Time Frame: Up to 2 hours per subject during the start of their participation in the study. ]Participants are given the Berlin Apnea questionnaire, the MASLACH burnout inventory, and the Owl and Lark Questionnaire during enrollment. The data from these questionnaires will be used for analysis purposes.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01672489
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Charles Czeisler, PH.D., M.D.||Brigham and Women's Hospital|